AIM ImmunoTech (AIM) Capital Leases (2010 - 2014)
AIM ImmunoTech's (AIM) quarterly Capital Leases came in at $3000.0 in Q3 2014, down 90.32% YoY from $31000.0 in Q3 2013, and down 57.14% on a QoQ basis from $7000.0 in Q2 2014.
AIM ImmunoTech (AIM) Capital Leases (2010 - 2014) Analysis & Trends
AIM ImmunoTech (AIM) has 5 years of Capital Leases data on file, last reported at $3000.0 in Q3 2014.
- Quarterly Capital Leases fell 90.32% year-over-year to $3000.0 in Q3 2014, while the trailing twelve-month figure through Sep 2014 was $3000.0 (down 90.32% YoY) and the FY2013 annual result came in at $23000.0, down 58.18% from the prior year.
- Capital Leases eased to $3000.0 in Q3 2014, from $7000.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $123000.0 in Q2 2011 to a low of $3000.0 in Q3 2014.
- A 5-year average of $57933.3 and a median of $55000.0 in 2012 frame the typical range for Capital Leases.
- Annual changes were most pronounced in 2011 — Capital Leases increased 3.12% — and 2014, when it tumbled 90.32%.
- Tracing AIM's Capital Leases over 5 years: stood at $96000.0 in 2010, then advanced by 3.12% to $99000.0 in 2011, then sank by 44.44% to $55000.0 in 2012, then plunged by 58.18% to $23000.0 in 2013, then tumbled by 86.96% to $3000.0 in 2014.
- The last three Capital Leases figures came in at $3000.0 (Q3 2014), $7000.0 (Q2 2014), and $15000.0 (Q1 2014), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | AIM ImmunoTech | 4.34 Mn | -5.62 Mn | 21,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 3,000.00 |
| Jun 30, 2014 | 7,000.00 |
| Mar 31, 2014 | 15,000.00 |
| Dec 31, 2013 | 23,000.00 |
| Sep 30, 2013 | 31,000.00 |
| Jun 30, 2013 | 37,000.00 |
| Mar 31, 2013 | 45,000.00 |
| Dec 31, 2012 | 55,000.00 |
| Sep 30, 2012 | 64,000.00 |
| Jun 30, 2012 | 73,000.00 |
| Mar 31, 2012 | 86,000.00 |
| Dec 31, 2011 | 99,000.00 |
| Sep 30, 2011 | 112,000.00 |
| Jun 30, 2011 | 123,000.00 |
| Dec 31, 2010 | 96,000.00 |